Dr. Moehring Awarded CDC Contract to Study Stewardship Metrics
Rebekah Moehring, MD, MPH has been awarded a contract with the Centers for Disease Control and Prevention to study ways to improve antimicrobial use metrics.
The CDC recently developed the Standardized Antimicrobial Administration Ratio (SAAR), a metric used to compare hospital’s antimicrobial use against a national standard. The metric is powered by data that hospitals submit via the National Healthcare Safety Network (NHSN).
Dr. Moehring’s work, entitled “Predictors of Antimicrobial Exposure for Application in the Standardized Antimicrobial Ratio Risk Adjustment Strategy”, will investigate ways to improve the SAAR’s ability to compare facilities as well as identify antimicrobial stewardship strategies for hospitals.
Dr. Moehring has previously worked with the CDC Foundation on metric development in antimicrobial stewardship. Working with a national panel of experts, Dr. Moehring and colleague Libby Dodds-Ashley, PharmD identified stewardship metrics based of usefulness and feasibility.
“Metrics for antimicrobial stewardship are important for two reasons. First, we need to know where opportunities to improve stewardship exist so we can target our efforts. Second, we need to assess the impact of stewardship interventions on prescribing practices and, more importantly, outcomes for patients,” says Dr. Moehring.
Drs. Moehring and Dodds-Ashley are faculty in the Duke Center for Antimicrobial Stewardship and Infection Prevention, a research, education, consulting and Duke Hospitals services group housed in the Duke School of Medicine’s Division of Infection Diseases.
The Center is proud to work with the CDC on several other projects, including as part of the CDC Prevention Epicenters Program, a multi-year collaboration among the nation’s top academic medical centers to enhance research around infectious diseases in the healthcare environment and improve patient safety.